|
UGDH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.042130E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.059780E-02 |
| Normal-vs-Stage2 |
8.581800E-04 |
| Normal-vs-Stage3 |
5.042900E-03 |
| Normal-vs-Stage4 |
1.752510E-04 |
| Stage1-vs-Stage2 |
8.890400E-02 |
| Stage1-vs-Stage3 |
3.964000E-01 |
| Stage1-vs-Stage4 |
3.739500E-02 |
| Stage2-vs-Stage3 |
2.926800E-01 |
| Stage2-vs-Stage4 |
9.181800E-01 |
| Stage3-vs-Stage4 |
2.976800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.576900E-03 |
| Normal-vs-AfricanAmerican |
5.368200E-02 |
| Normal-vs-Asian |
1.220200E-01 |
| Caucasian-vs-AfricanAmerican |
9.778600E-01 |
| Caucasian-vs-Asian |
7.715600E-01 |
| AfricanAmerican-vs-Asian |
8.376600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.959200E-03 |
| Normal-vs-Female |
4.520300E-03 |
| Male-vs-Female |
9.606800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.168760E-01 |
| Normal-vs-Age(41-60Yrs) |
4.043200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.68255999999367E-05 |
| Normal-vs-Age(81-100Yrs) |
7.388200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.996230E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.298540E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.256600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.991410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.003400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.288450E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.411700E-02 |
| Classical-VS-Follicular |
2.04719999999936E-05 |
| Classical-VS-Other |
4.367000E-01 |
| Classical-VS-Normal |
9.380100E-02 |
| Tall-VS-Follicular |
2.139400E-01 |
| Tall-VS-Other |
9.484800E-01 |
| Tall-VS-Normal |
1.983890E-03 |
| Follicular-VS-Other |
5.240000E-01 |
| Follicular-VS-Normal |
1.49810000005246E-06 |
| Other-VS-Normal |
1.216560E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.437200E-04 |
| Normal-vs-N1 |
2.184400E-04 |
| N0-vs-N1 |
4.365200E-01 |
|
|
